Botanical species · safety record

Astracantha gummifera

The EFSA Compendium of Botanicals holds 1 constituent measurement and 3 adverse-effect records for Astracantha gummifera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Astracantha gummifera (Labill.) Podlech.

1Constituent measurements
3Safety records
2Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Astragaloside iv1

Plant parts

  • Roots and other underground parts1

Preparations

  • Gum (as part-nature)3
  • Solvent extraction1

Effect types

  • Digestive3

Target tissues

  • Digestive3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Astragaloside ivRoots and other underground partsSolvent extractionNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveGum (as part-nature)Rat (as animal)In vitroNo resolvable identifier
DigestiveDigestiveGum (as part-nature)Rat (as animal)In vitroNo resolvable identifier
DigestiveDigestiveGum (as part-nature)Rat (as animal)In vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yusufoglu, H. S., Alam, A. Isolation of Astragaloside IV and Cyclocephaloside I from Astragalus gummifera and evaluation of Astragaloside IV ON CCL4 induced liver damage in rats. PLANTA MEDICA, 2014, vol. 80, no. 10, p. 799-799.
  2. Hassan, Hazem M. M. Inhibitory activities of some mucilages and gums against certain intestinal disaccharidases.. Australian Journal of Basic and Applied Sciences, 2009, vol. 3, no. 3, p. 2741-2746.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue